Sanofi’s tolebrutinib drug delays progressive MS by 31% in trial By Reuters
By Ludwig Burger FRANKFURT (Reuters) -Sanofi stated on Friday that its a…
Search
Have an existing account?
Sign In
By Ludwig Burger FRANKFURT (Reuters) -Sanofi stated on Friday that its a…
